Document is current
Any future updates will be listed below
-
Authors
Couey, Marcus A.
Bell, R. Bryan
Patel, Ashish A.
Romba, Meghan C.
Crittenden, Marka R.
Curti, Brendan D.
Urba, Walter J.
Leidner, Rom S.
- License Information
-
More Information
Article History
Received: 18 March 2019
Accepted: 19 June 2019
First Online: 3 July 2019
Ethics approval and consent to participate
: The study was conducted under institutional review board approval at Providence Portland Medical Center, Oregon. Waiver of consent was obtained for retrospective chart review.
: No personal identifying information was included in the manuscript, and therefore no consent was required.
: RBB receives research funding from the Oral and Maxillofacial Surgery Foundation, BMS, Abbvie, Safeway Foundation, Providence Portland Medical Center Foundation, receives institutional support from BMS, MedImmune, Prometheus, Merck, and is a member of the speakers bureaus for Merck and BMS, MRC receives institutional research support from Nanobiotix, Jounce, Celldex, Mavupharma and BMS, BDC receives institutional research support from MedImmune/AstraZeneca, BMS, Viralytics, and Gallectin Therapeutics, and serves as consultant to BMS, Eisai, Alligator, and Iovance, WJU has received renumeration from MedImmune and Leidos Biomedical Research, serves on the board of directors for Leidos, and serves on the advisory board for Bionical EMAS, RSL receives institutional research support from Bristol Myers Squibb and Medimmune/AstraZeneca, and serves as a consultant to Merck and Regeneron.
